Vaccine:趣味医学心理学——如何更有效的劝说别人打疫苗?

2021-01-14 MedSci原创 MedSci原创

如果你希望家人朋友能够乖乖接种疫苗,最好的方式就是让医生告诉他,这个疫苗可以打,必须打。

目前陆续有新闻报道新冠疫情有复发的迹象,特别是面对寒冷的气温还有即将到来的春运都让人们对未来的疫情发展形势十分的担忧。但另一方面,全国各地都开始推广新冠疫苗的接种行动了。国家卫生健康委疾控局监察专员王斌表示,自2020年12月15日新冠病毒疫苗重点人群接种工作实施以来,疫苗接种量已超1000万剂次。多地在接种过程中总结了许多有益做法,总体来看,全国新冠疫苗接种平稳有序。

然而,好像也并不是所有人都愿意接种疫苗,有一些在医院工作的朋友就表示,“医院最近发了通知,如果愿意接受疫苗接种的就登记,不愿意的话就算了,纯属自愿原则。但我觉得好像可打可不打,现在医院管控比较严,病人进来都要做核酸,我们定期也都在查,而且刚上市的疫苗也不太稳定……”

除了这种情况,不愿意打疫苗可能还有很多其他原因,比如怕疼、懒、不想去医院……这让很多关心他们的人十分困扰。

那么怎样才能让你关心的家人或者朋友乖乖去打疫苗呢?近日,Vaccine上就发表了一篇相关的研究,虽然在这篇研究中提到的是HPV疫苗而不是新冠疫苗,主角是青少年也不是成人,但本质讲的是同一件事,而且考虑到有些成人可能比小孩子还顽固,所以方法还是可以借鉴一下的。

在这篇研究中,研究者通过对有资格接种HPV疫苗、脑膜炎球菌疫苗的青少年的临床沟通的音频记录,分析了关于是否接种疫苗的临床沟通并测量了谈话时间的长短,医务工作者分别使用指示性(就诊时一语道明需要接种疫苗)或选择性的(接种疫苗是可选的)推荐方式。从访前和访后的调查中收集父母和儿童的人口统计数据、父母接种疫苗的意向以及父母对疫苗接种讨论的满意度。分别使用线性回归和随机效应logit回归来估计推荐风格与沟通时长和疫苗接种次数的关系。

研究者共分析了106例疫苗接种临床谈话(82例HPV;24例脑膜炎球菌)。当医务工作者将疫苗接种作为选择性 (140 vs. 74 s; p-value < 0.001)的方式进行交谈时,会比指示性多出更多的交谈时间。在控制疫苗类型、父母接种意图和患者特征的情况下,选择式与谈话延长41秒相关(p-value < 0.05)。与HPV疫苗相比,脑膜炎球菌疫苗的提供者更频繁地使用指示类型谈话(96% vs. 72%; p-value < 0.05),父母接种疫苗的几率比选择性接种高9.3倍(p-value < 0.05)。接种疫苗谈话时间的长短以及谈话的类型都与父母的满意度无关。

研究最终得出的结论为,使用肯定的建议可以提高疫苗讨论的效率和有效性,增强HPV疫苗指定样式的沟通方式,有可能提高疫苗接种率并节省就医时间。

看到这里大家是否会有一些疑问,想要质疑这篇文章的价值?其实HPV疫苗的接种争议一直都是有的,所以很多医务工作者在临床中也是更多的遵循患者的意见,而接种脑膜炎球菌疫苗的必要性可能更为直接,医生在沟通时也会更多的持肯定态度。

研究结论其实也很简单,就好像现在很火的直播带货,主播会说:买它!你就会潜移默化的有购买的冲动,但告诉你这个东西你可买不买,你当然就会犹豫啦!

所以,如果你希望家人朋友能够乖乖接种疫苗,最好的方式就是让医生告诉他,这个疫苗可以打,必须打。大家还有什么其他意见,可以在下方评论区讨论~

参考文献:Anny T.H.R. Fenton, Chelsea Orefice, Terresa J. Eun, Dea Biancarelli, Amresh Hanchate, Mari-Lynn Drainoni, Rebecca B. Perkins. Effect of provider recommendation style on the length of adolescent vaccine discussionsVaccine, 2021; DOI: 10.1016/j.vaccine.2020.11.015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-03-27 kalseyzl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-03-31 1302a2dfm45暂无昵称

    必须打

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-16 ms1000000880603017

    进来好好学习一下内容

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-16 lilili1108
  6. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-15 水-晶

    继续来看看

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-15 1486adbfm03暂无昵称

    好闻

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-15 Baodongxu

    前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普#新冠肺炎##疫苗#

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-14 言西早

    使用肯定的建议可以提高疫苗讨论的效率和有效性。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1773906, encodeId=b7e51e7390641, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Mar 27 14:39:28 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952572, encodeId=c6bf9525e247, content=必须打, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5833436115, createdName=1302a2dfm45暂无昵称, createdTime=Wed Mar 31 08:34:17 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917157, encodeId=2acf91e1575e, content=进来好好学习一下内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad295453301, createdName=ms1000000880603017, createdTime=Sat Jan 16 15:44:43 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326723, encodeId=cb4b1326e2389, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540328, encodeId=90da154032802, content=<a href='/topic/show?id=9e0e929e4c8' target=_blank style='color:#2F92EE;'>#趣味#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92974, encryptionId=9e0e929e4c8, topicName=趣味)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0aa13204518, createdName=lilili1108, createdTime=Sat Jan 16 12:39:28 CST 2021, time=2021-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917039, encodeId=469e91e039a4, content=继续来看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Jan 15 23:57:12 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917036, encodeId=a87491e036d4, content=好闻 , beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Fri Jan 15 23:49:35 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916854, encodeId=4d3091685467, content=前些天和一个人一起坐**车,给他和司机科普了一下为什么要打疫苗,老百姓还是对未知事物首先表现出恐惧与不信任的。要加强科普<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a><a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=70487, encryptionId=62afe048720, topicName=疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Fri Jan 15 11:36:07 CST 2021, time=2021-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916685, encodeId=4b4c91668526, content=使用肯定的建议可以提高疫苗讨论的效率和有效性。, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4gCIdSaEkahCNuUWZv4iaKmqvUKHyKnBiarBM9RStQKBeV5Lh6GYYFiamdV5KlSfbLvmAgZTLtq81XA/0, createdBy=13511650672, createdName=言西早, createdTime=Thu Jan 14 23:34:50 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916662, encodeId=2fb691666212, content=进来看看学习下, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Thu Jan 14 22:27:35 CST 2021, time=2021-01-14, status=1, ipAttribution=)]
    2021-01-14 水-晶

    进来看看学习下

    0

相关资讯

中国艾滋病疫苗或明年开启III期临床试验,有望突破HIV困局

艾滋病是一种全球性疾病,蔓延速度快,死亡率高。自1981年首次发现艾滋病以来,HIV的感染在世界范围内迅速流行。至2002年底世界上至少有193个国家和地区发现有HIV感染者死亡,且其仍以每天感染 1

NEJM:辉瑞/BioNTech新冠mRNA疫苗有效率为95%!FDA将紧急应用授权

上周三,英国率先批准了辉瑞-BioNTech联合研发的新冠疫苗用于紧急用途,本周已在英国进行较大范围接种。当时有声音批评英国太着急了。事实上,英国是基于疫苗的III期临床试验结果而批准的。本周研究结果

首批5000万人,我国新冠疫苗1月15日开打!打了疫苗后还要不要戴口罩?

12月19日,国务院联防联控机制举行新闻发布会,表示将在全国范围内对重点人群进行新冠疫苗接种。据业内消息,我国首批新冠疫苗首针将在1月15日接种完成,第二针将在2月15日接种完成,预计先接种5000万

DeltaTrak的全新疫苗供应链解决方案满足COVID-19疫苗存储、处理和运输所需的所有三种温度管理要求

DeltaTrak®宣布了定制的疫苗温度监控解决方案,能满足COVID-19疫苗运输、存储和处理所需的三种温度要求。

国家药监局:已建设疫苗信息化追溯体系 基本实现上市疫苗全程追溯管理

据中央广播电视总台中国之声《新闻晚高峰》报道,疫苗是战胜流行病疫情的重要武器,但是其安全性和有效性始终是第一位的。国家药品监督管理局药品审评中心副主任王涛9日在接受总台央广记者采访时表示,国家药监局坚

新加坡卫生科学局批准继续进行ARCT-021(LUNAR-COV19)疫苗的II期临床研究

领先的临床阶段信使RNA药品公司Arcturus Therapeutics今天宣布,该公司已获得新加坡卫生科学局的批准,可以对其候选疫苗ARCT-021进行II期临床研究。